Vaccines Current Events

Vaccines Current Events, Vaccines News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
'Dose sparing' flu vaccine could boost productivity and vaccine availability
The currently licensed seasonal trivalent influenza vaccines contain 15 micrograms of viral hemagglutinin protein per strain for adults, and up to 60 micrograms for elderly individuals; however, due to recent shortages, reducing these doses would be highly desirable. A recent study has found that significant dose sparing is possible with the use of whole virion vaccines and aluminum adjuvants, without compromising safety. (2017-04-05)

Are influenza vaccines worth the effort?
Each year enormous effort goes into producing influenza vaccines and delivering them to appropriate sections of the population. But a review of the evidence in this week's BMJ suggests that they may not be as effective as we think. (2006-10-26)

No adverse effects of aluminium in vaccines
Writing in the February issue of The Lancet Infectious Diseases, Tom Jefferson and colleagues (Cochrane Vaccines Field, Rome, Italy) report that aluminium in vaccines for diphtheria, tetanus, and pertussis causes no serious or long-lasting adverse effects. (2004-01-28)

When developing vaccines against COVID-19, 'fast is slow, and slow is fast'
Bypassing clinical trials for a potential SARS-CoV-2 vaccine would be ''catastrophic,'' says Science Advances deputy editor Douglas Green in this Editorial. Instead, it's vital to take time to ensure any vaccine candidate's safety and investigate potential adverse (2020-05-22)

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes. (2020-11-04)

Designing vaccines by computer
Having vaccines developed by computer may sound unnerving but the increasing role of computer modelling in the development of new vaccines could bring new products onto the market quicker, benefiting patients and saving pharmaceutical companies millions of pounds. (2005-04-12)

Danish researchers behind vaccine breakthrough
A Danish research team from the University of Copenhagen has designed a simple technique that makes it possible to quickly and easily develop a new type of vaccines. The simple and effective technique will pave the way for effective vaccines against not only infectious diseases but also cancer and other chronic diseases. (2016-04-26)

Vaccine shows promise against widespread chicken disease
A new vaccine strategy could offer protection to millions of chickens threatened by a serious respiratory disease, research shows. (2018-10-23)

Nasal spray vaccines more effective against flu
Nasal vaccines that effectively protect against flu, pneumonia and even bioterrorism agents such as Yersinia pestis that causes the plague, could soon be a possibility, according to research presented at the Society for General Microbiology's Spring Conference in Harrogate. Professor Dennis Metzger describes how including a natural immune chemical with standard vaccines can boost their protective effect when delivered through the nose. (2011-04-11)

Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
In an article that appears in the journal Nature, Dennis Burton, PhD, and Eric Topol, MD, of Scripps Research call for governments to provide significant funding support for rational vaccine design based on broadly neutralizing antibodies. Such antibodies provide broad-spectrum potency against viruses, a valuable characteristic that opens the door to vaccines that could provide immunity against the many variants that might evolve from a fast-mutating virus. They could also be used as drugs to prevent and treat infections. (2021-02-09)

Oct. 14 Web cast: Reporter's Workshop -- Covering Vaccines & Immunizations
The National Partnership for Immunization invites you to an important discussion about the complex world of vaccines, especially timely with last week's news of the influenza vaccine shortage. (2004-10-11)

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M. Knipe and colleagues in this Perspective. (2020-11-17)

Rino Rappuoli honored for his work in vaccines and vaccinology
Dr. Rino Rappuoli has been chosen to receive the 2011 ESCMID Award for Excellence on Clinical Microbiology and Infectious Diseases by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). He has been awarded the prize in recognition of his outstanding contributions in the field of vaccines and vaccinology. The award of €10,000 will be presented to the researcher at the 21st ECCMID / 27th ICC meeting in Milan, Italy, which takes place from May 7-10, 2011. (2011-05-06)

Research may lead to new and improved vaccines
Alum is an adjuvant (immune booster) used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine. (2011-03-14)

Antibodies for new rotavirus vaccines
CSIRO has been contracted by PATH (Program for Appropriate Technology in Health) to produce antibodies on a large scale that will aid the development of new, safe, affordable and effective vaccines against rotavirus, a major cause of severe and fatal diarrhea in young children worldwide. (2012-07-16)

Different patients need different needle sizes
A standard size needle does not guarantee successful administration of vaccines in all people, especially for patients over a certain weight, according to an editorial in this week's BMJ. (2000-11-16)

Zika vaccines offer full protection to monkeys
Analysis of three types of Zika vaccines reveal that they are effective at protecting rhesus monkeys from the virus, a new study reports. (2016-08-04)

IVAC Executive Director Dr. Orin Levine commends Gates Foundation announcement
Today, the Bill & Melinda Gates Foundation announced it would dedicate $10 billion over the next ten years to support vaccine research, development and delivery throughout the developing world. This commitment is unprecedented. IVAC Executive Director Dr. Orin Levine commends this announcement. (2010-01-29)

Key benefits of large-scale use of universal over conventional flu vaccines
Universal vaccines that protect against multiple strains of influenza virus at once could offer key population-level benefits over conventional seasonal vaccines, according to a new study published in PLOS Computational Biology. (2016-12-15)

The risk of autism is not increased by 'too many vaccines too soon'
Nearly one in 10 parents refuse or delay vaccinations because they believe it is safer than following the CDC's schedule. A primary concern is the number of vaccines administered, both on a single day and cumulatively over the first two years of life. In a new study scheduled for publication in The Journal of Pediatrics, researchers concluded that there is no association between receiving (2013-03-29)

Researcher issues caution on live virus vaccines
A New York Medical College microbiologist warns that live virus vaccines to prevent infectious diseases like West Nile virus and yellow fever could have dire consequences. Should one of the vaccine flaviviruses recombine with a wild-type virus, a new microbe with potentially undesirable properties could result, according to Stephen J. Seligman, M.D., research professor of microbiology and immunology, in a recent article published in Lancet. (2004-06-18)

Iowa State University researcher develops vaccine for H1N1 flu virus in swine
The H1N1 virus has now been found in a Canadian swine herd, and an Iowa State University researcher has developed an H1N1 flu vaccine for pigs. (2009-05-06)

Academy meeting examines the vaccine & avian influenza crisis
Effective vaccinations against influenza were established many years ago. However, lack of availability of vaccines and the potential for new influenza subtypes to spread in pandemics represent new challenges to global public health. The New York Academy of Sciences is presenting a discussion, (2004-11-30)

European patent awarded for anti-cancer vaccine technology
The European Patent Office has awarded the patent for a technology that is proving to be key to efforts to protect women against cervical cancer to a team of scientists at the University of Rochester Medical Center. (2005-06-27)

Influenza vaccination programmes for children in USA and Canada based on little evidence
Children in the USA and Canada are being vaccinated against influenza without adequate proof that it will work, concludes a study published in this week's issue of The Lancet. (2005-02-24)

Conference focuses on vaccines for chronic diseases
At a symposium sponsored by the University of Texas Medical Branch at Galveston and scheduled for Feb. 7-9, an international group of researchers will discuss development of vaccines for addiction, cancer, chronic infectious diseases and neurodegenerative diseases. (2012-02-03)

High-dose flu vaccines appear to safely boost immunity in elderly
High-dose influenza vaccines may increase elderly patients' immune response without significant adverse effects, offering this vulnerable population additional protection against the flu, according to an article in the May 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. (2006-05-22)

Better vaccines for tuberculosis could save millions of lives
Cases of one of the world's deadliest diseases -- tuberculosis -- are rising at an alarming rate, despite widespread vaccination. Reasons for the ineffectiveness of the vaccine, especially in regions where this infectious disease is endemic, as well as arguments for replacing the existing vaccine with novel synthetic vaccines, are presented in a review published online Aug. 28 in Trends in Molecular Medicine. (2012-08-28)

First metritis vaccine protects dairy cows
Cornell scientists have created the first vaccines that can prevent metritis, one of the most common cattle diseases. The infection not only harms animals and farmers' profits, but also drives more systemic antibiotic use on dairy farms than any other disease. The new vaccines prevent metritis infection of the uterus from taking hold and reduce symptoms when it does, a prospect that could save the United States billions of dollars a year and help curb the growing epidemic of antibiotic resistance. (2014-04-16)

Large-scale COVID-19 vaccine production will require knowledge transfer on manufacturing
Massive, rapid production of vaccines to fight COVID-19 will require firms to share know-how not just about what to make, but how to make it, write Nicholson Price and colleagues in this Policy Forum. (2020-08-13)

Vaccines can cut the spread of meningitis by nearly 40 percent
Investigators at the University of Southampton have discovered that two new vaccines can prevent the transmission of meningitis bacteria from person to person. (2014-08-18)

Research brief: Vaccines to treat opioid abuse and prevent fatal overdoses
A team of scientists from the University of Minnesota Medical School and Minneapolis Medical Research Foundation at Hennepin Healthcare is developing vaccines against heroin and prescription opioids, such as oxycodone and fentanyl. (2018-04-11)

Report focuses on challenges to unlocking future promise of vaccines
Vaccines have helped eradicate and tame some of history's worst infectious diseases, but there are many more diseases out there that vaccines can help overcome. The challenges society needs to confront to unlock the future promise of vaccines against the plagues of the 21st century are the focus of a new report by the American Academy of Microbiology. (2005-10-07)

Adjuvant combo shows potential for universal influenza vaccine
Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to boost influenza vaccine effectiveness. A combination of two adjuvants induced killer T cells to join antibodies in response to influenza infection. Since the killer T cells targeted a highly conserved protein that does not change from year to year, the adjuvant strategy suggests potential for a universal flu vaccine. (2011-06-07)

Aspirin, tylenol may decrease effectiveness of vaccines
With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. Although those vaccines are expected to be effective, University of Missouri researchers have found further evidence that some over-the-counter drugs, such as aspirin and Tylenol, that inhibit certain enzymes could impact the effectiveness of vaccines. (2009-12-01)

Could self-disseminating vaccines cut off emerging infectious diseases at source?
An expert review identifies state-of-the-art of self-disseminating vaccines as a new and potentially powerful strategy to circumvent diseases such as Ebola at the animal source before their establishment as the next human pandemic (2015-11-01)

Synthetic biologists use bacterial superglue for faster vaccine development
Technique uses strong isopeptide bonds to link virus-like particles and antigens to create viral vectored vaccines with fewer errors. (2016-01-19)

Vaccine and autism debate masks real problem
The bitter debate over whether vaccines cause autism is masking real problems with the modern inoculation schedule and encouraging a growing number of parents to refuse recommended vaccines for their children, argues a Michigan State University scholar. (2012-08-22)

NIH officials highlight COVID-19 vaccine facts, unknowns for healthcare providers
Healthcare providers must be able to explain the latest data supporting the safety and efficacy of vaccines for coronavirus disease 2019 (COVID-19) so they can strongly encourage vaccination when appropriate while acknowledging that uncertainty and unknowns remain. This message comes from a new commentary co-authored by Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and other leading NIAID scientists in the journal Annals of Internal Medicine. (2021-01-18)

Vaccine puts blood-sucking ticks off their food
A new solution to controlling tick-borne diseases of animals and humans is the development of vaccines against the ticks and not the microbes that cause the diseases. (2002-04-08)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.